Publications by authors named "M H Kalos"

Claim this Profile
G
Going with the Flow: Circulating Tumor-Reactive Lymphocytes Stream into Cancer Therapy.
Rubén Alvarez-Rodríguez, Aleksandra Vuchkovska, Zongjie Wang, Cecile Chartier, Kristen Hege, Michael Kalos

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products.
Mark D Stewart, Michael Kalos, Vicki Coutinho, Marc Better, Jonathan Jazayeri

Cytotherapy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models.
Yanxia Li, Nelusha Amaladas, Marguerita O'Mahony, Jason R Manro, Ivan Inigo, Michael Kalos

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity.
Helen Kotanides, Yiwen Li, Maria Malabunga, Carmine Carpenito, Scott W Eastman, Michael Kalos

Cancer Immunol Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity.
Helen Kotanides, Rose Marie Sattler, Maria B Lebron, Carmine Carpenito, Juqun Shen, Michael Kalos

Mol Cancer Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis